US › Healthcare

Akanda Corp (AKAN)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$2.94+8.09%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$258,075

Revenue YoY

-66.2%

Net profit

$-44.8M

EPS

$-2.02

EPS estimate

$0.00

Net margin

-17,342.7%

Key statistics

Market cap

$1.6M

Forward P/E

0.0

P/B

2.21

Book value

$-15.59

EPS (TTM)

$-15,065.55

52-week high

$118.45

52-week low

$2.30

50-day MA

$6.45

200-day MA

$10.89

Beta

14.15

Shareholding

Insiders

0.59%

Institutions

0.04%

Largest institutional holders

Fund	Stake
SBI Securities Co Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Akanda Corp — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.